Skip to content
  • Report Harm
  • Newsletter
  • Shop
  • Media Kit
Facebook Linkedin Twitter RSS YouTube Instagram
Benzodiazepine Information Coalition
  • About BenzodiazepinesExpand
    • Benzo BasicsExpand
      • Ashton Manual
      • A Brief History Of Benzodiazepines
      • Class Actions and Lawsuits—and Reporting Harm 
      • FDA 2020 Benzodiazepine Boxed Warning
      • Medications and Supplements of Concern
      • Xanax Study Outcomes
    • PrescribingExpand
      • Addiction vs Physical Dependence
      • Genetic Testing
      • Informed Consent
      • Low Dose Benzodiazepines
      • Mechanism of Action
      • Prescribing Statistics
      • Steps to Reduce Benzodiazepine Overprescribing
      • Therapeutic Actions
    • Prescribing RisksExpand
      • Akathisia
      • Fluoroquinolones
      • Functional Brain Changes
      • Interdose Withdrawal
      • Paradoxical Reactions
      • Physical Dependence
      • Risks of Remaining on Benzodiazepines
      • Red Flags
      • Short-Term Risks
      • Side Effects
      • Suicide
      • Tolerance
    • DeprescribingExpand
      • Ashton Manual
      • Tapering Strategies and Solutions
      • Detox, Cold Turkey, Abrupt Cessation
      • Estimates of Withdrawal
      • How To Find Tapering Help
      • Dosages Prevent Safe Withdrawal
      • Why Patients Shouldn’t Go To Detox or Rehab
    • Desprescribing RisksExpand
      • Akathisia
      • Benzodiazepine Withdrawal Syndrome (BWS)
      • Forced Switching or Stopping
      • Functional Brain Changes
      • Kindling
      • Protracted Withdrawal Syndrome (PWS)
      • Suicide
      • Withdrawal & Post Withdrawal Symptoms
    • Special PopulationsExpand
      • Benzodiazepines and PTSD
      • Celebrities
      • COVID-19
      • Elderly
      • Women
      • Incarcerated Population
      • Substance Use Disorders
  • About UsExpand
    • Media Kit
    • VolunteerExpand
      • Media Interview List Registration
      • Informed Consent Policy
      • FDA Reporting Program
      • Share Your Story!
  • Our Impact
  • ResourcesExpand
    • Ashton Manual
    • Benzodiazepine Tapering Strategies and Solutions
    • Financial and Disability Information
    • How To Find Tapering Help
    • Benzodiazepine Cooperative Providers
  • Blog
  • Contact UsExpand
    • Receive Our Newsletter
  • Donate
Donate
Facebook Linkedin Twitter Phone RSS Instagram
Benzodiazepine Information Coalition

Media Interview List Registration

As the benzodiazepine problem picks up steam, we are receiving more and more media requests.  Many times these requests are for interviews with victims, both recovered and still suffering.  Should you have interest in being included in a future news segment or article and feel comfortable telling your story we would like to hear from you! The only requirements you must meet include: (1) your story must be one of taken-as-prescribed harm (sorry, but because of our mission/objectives, we typically do not get requests for addiction/abuse stories); and (2) you must not use what we call “addiction terminology” (e.g., words like ‘hooked,’ ‘clean,’ ‘addicted,’ etc.) in your interview with the media, should you be chosen.

To let us know of your interest, we are asking that you submit a brief profile. Journalists that contact us typically are looking for a particular demographic (e.g., male, female, elderly, 20-somethings, etc.) and are on a short deadline. This often leaves us scrambling to find the perfect fit.  Having a “library” of different stories at our fingertips would help immensely.

Please fill out our form if you wish to participate: 

Contact Us

Inquiries:
bic@benzoinfo.com

We do not offer any support services or guidance. See our resources for services and support.

Mailing Address:
1042 Ft. Union Blvd, PMB 1030
Midvale, Utah 84047

Support Us

We were formed to change the lack of knowledge in the public and the medical system. But we cannot do it alone. We rely solely on donations to operate. We are a 501(c)(3) tax exempt organization.

DONATE

Newsletter

Receive the latest benzodiazepine activism news, events and calls to action.

Notices

Benzodiazepine Information Coalition is a 501(c)3 tax exempt organization.

EIN: 81-3442343

Privacy Policy
Medical Disclaimer
Terms and Conditions
Free Charity Hosting by Kualo

Twitter Facebook Linkedin YouTube Instagram

© 2022 Benzodiazepine Information Coalition

Scroll to top
  • About Benzodiazepines
    • Benzo Basics
      • Ashton Manual
      • A Brief History Of Benzodiazepines
      • Class Actions and Lawsuits—and Reporting Harm 
      • FDA 2020 Benzodiazepine Boxed Warning
      • Medications and Supplements of Concern
      • Xanax Study Outcomes
    • Prescribing
      • Addiction vs Physical Dependence
      • Genetic Testing
      • Informed Consent
      • Low Dose Benzodiazepines
      • Mechanism of Action
      • Prescribing Statistics
      • Steps to Reduce Benzodiazepine Overprescribing
      • Therapeutic Actions
    • Prescribing Risks
      • Akathisia
      • Fluoroquinolones
      • Functional Brain Changes
      • Interdose Withdrawal
      • Paradoxical Reactions
      • Physical Dependence
      • Risks of Remaining on Benzodiazepines
      • Red Flags
      • Short-Term Risks
      • Side Effects
      • Suicide
      • Tolerance
    • Deprescribing
      • Ashton Manual
      • Tapering Strategies and Solutions
      • Detox, Cold Turkey, Abrupt Cessation
      • Estimates of Withdrawal
      • How To Find Tapering Help
      • Dosages Prevent Safe Withdrawal
      • Why Patients Shouldn’t Go To Detox or Rehab
    • Desprescribing Risks
      • Akathisia
      • Benzodiazepine Withdrawal Syndrome (BWS)
      • Forced Switching or Stopping
      • Functional Brain Changes
      • Kindling
      • Protracted Withdrawal Syndrome (PWS)
      • Suicide
      • Withdrawal & Post Withdrawal Symptoms
    • Special Populations
      • Benzodiazepines and PTSD
      • Celebrities
      • COVID-19
      • Elderly
      • Women
      • Incarcerated Population
      • Substance Use Disorders
  • About Us
    • Media Kit
    • Volunteer
      • Media Interview List Registration
      • Informed Consent Policy
      • FDA Reporting Program
      • Share Your Story!
  • Our Impact
  • Resources
    • Ashton Manual
    • Benzodiazepine Tapering Strategies and Solutions
    • Financial and Disability Information
    • How To Find Tapering Help
    • Benzodiazepine Cooperative Providers
  • Blog
  • Contact Us
    • Receive Our Newsletter
  • Donate
Search
Open toolbar

Accessibility Tools

  • Increase Text
  • Decrease Text
  • Grayscale
  • High Contrast
  • Negative Contrast
  • Light Background
  • Links Underline
  • Readable Font
  • Reset